Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). EnBio Holdings's share price for the quarter that ended in Mar. 2026 was 円763. EnBio Holdings's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 8 Mil. Therefore, EnBio Holdings's market cap for the quarter that ended in Mar. 2026 was 円6,194 Mil.
EnBio Holdings's quarterly market cap
declined
from Sep. 2025 (円4,860 Mil) to Dec. 2025 (円4,844 Mil) but then
increased
from Dec. 2025 (円4,844 Mil) to Mar. 2026 (円6,194 Mil).
EnBio Holdings's annual market cap
declined
from Mar. 2024 (円4,915 Mil) to Mar. 2025 (円4,852 Mil) but then
increased
from Mar. 2025 (円4,852 Mil) to Mar. 2026 (円6,194 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. EnBio Holdings's Enterprise Value for Today is 円12,605 Mil.
EnBio Holdings (TSE:6092) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
EnBio Holdings Market Cap Related Terms
EnBio Holdings Market Cap Historical Data
* Premium members only.
The historical data trend for EnBio Holdings's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:6092 vs CTAS, CPRT, ULS: Market Cap Comparison
For the Specialty Business Services subindustry, EnBio Holdings's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
EnBio Holdings Market Cap vs Business Services Industry
For the Business Services industry and Industrials sector, EnBio Holdings's Market Cap distribution charts can be found below:
* The bar in red indicates where EnBio Holdings's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
EnBio Holdings's Market Cap for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EnBio Holdings (TSE:6092) has a Market Cap of 円5,910 Mil as of Jul. 17, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on EnBio Holdings and its competitors. According to the industry distribution chart, EnBio Holdings ranks #639 out of 1117 companies in the Business Services industry, placing it in the top 57.2%.
Is EnBio Holdings' Market Cap too high?
EnBio Holdings' current Market Cap is 円5,910 Mil. Based on the distribution chart, EnBio Holdings ranks #639 out of 1117 companies in the Business Services industry, which is below the industry midpoint. Overall, EnBio Holdings has a GF Score™ of 58/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does EnBio Holdings' Market Cap compare to CTAS and CPRT?
According to the Business Services industry distribution chart, EnBio Holdings ranks #639 out of 1117 companies for Market Cap. This places EnBio Holdings in the lower half of its industry. The industry median Market Cap is 55.77. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Business Services company?
The median Market Cap among Business Services companies is 55.77, based on 1,117 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on EnBio Holdings and its competitors. For the Business Services industry, the median Market Cap is 55.77 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. EnBio Holdings's current Market Cap is 円5,910 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EnBio Holdings stock overvalued right now?
Based on GuruFocus' analysis, EnBio Holdings (TSE:6092) is currently considered Fairly Valued. The stock's GF Value™ is 円799.37, compared to a current price of 円728.00 — trading 8.9% below its estimated fair value. The current Market Cap is 円5,910 Mil. EnBio Holdings' overall GF Score™ is 58/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For EnBio Holdings (TSE:6092), the current Market Cap is 円5,910 Mil as of Jul. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is EnBio Holdings (TSE:6092) Overvalued in 2026?
Based on GuruFocus' analysis, EnBio Holdings stock appears to be undervalued.
The current stock price of 円728.00 is trading 8.9% below its estimated GF Value™ of 円799.37.
GuruFocus considers EnBio Holdings to be Fairly Valued.
Key valuation signals for TSE:6092:
Market Cap: 円5,910 Mil
GF Value™: 円799.37 vs. price of 円728.00 (8.9% below fair value)
No single metric tells the full story. See the TSE:6092 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
EnBio Holdings Inc is a Japanese company engaged in environmental solution business, tools and chemicals business, and brownfield revitalization business. The environmental business involves investigation, remediation and risk management consulting of contaminated soil and groundwater; Tools and chemicals business involves sales of chemicals used for environmental work such as site investigation and remediation; and brownfield revitalization business which involves purchasing and regeneration of brownfields. The objective of the company is solving soil and groundwater contamination issues.
58GF Score
Get the complete analysis for TSE:6092
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:6092 has been successfully added to your 
